News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,545 Results
Type
Article (76755)
Company Profile (720)
Press Release (777048)
Multimedia
Podcasts (231)
Webinars (35)
Section
Business (228432)
Career Advice (3756)
Deals (39586)
Drug Delivery (178)
Drug Development (90106)
Employer Resources (207)
FDA (18314)
Job Trends (17289)
News (390125)
Policy (39046)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (1)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (207)
Alliances (56141)
ALS (236)
Alzheimer's disease (1979)
Antibody-drug conjugate (ADC) (560)
Approvals (18668)
Artificial intelligence (827)
ASCO (344)
Autoimmune disease (362)
Automation (65)
Bankruptcy (405)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (438)
Bladder cancer (210)
Brain cancer (85)
Breast cancer (838)
Cancer (6606)
Cardiovascular disease (558)
Career advice (3234)
Career pathing (52)
CAR-T (386)
CDC (76)
Celiac Disease (3)
Cell therapy (1052)
Cervical cancer (56)
Clinical research (77898)
Collaboration (2398)
Commercialization (1)
Company closure (7)
Compensation (1533)
Complete response letters (106)
COVID-19 (3042)
CRISPR (126)
C-suite (1305)
Cystic fibrosis (168)
Data (8788)
Decentralized trials (3)
Denatured (88)
Depression (196)
Dermatology (97)
Diabetes (709)
Diagnostics (7597)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (402)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (99739)
Editorial (79)
Employer branding (25)
Employer resources (174)
Events (137633)
Executive appointments (1202)
FDA (22415)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1956)
Gene editing (271)
Generative AI (78)
Gene therapy (843)
GLP-1 (1285)
Government (5512)
Grass and pollen (8)
Guidances (420)
Healthcare (21243)
Hematology (197)
HIV (97)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (355)
Immuno-oncology (116)
Indications (213)
Infectious disease (3445)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (151)
Intellectual property (323)
Interviews (736)
IPO (17931)
IRA (61)
Job creations (5008)
Job search strategy (2604)
JPM (73)
Kidney cancer (22)
Labor market (123)
Layoffs (685)
Leadership (53)
Legal (9972)
Liver cancer (111)
Longevity (36)
Lung cancer (874)
Lymphoma (481)
Machine learning (66)
Management (66)
Manufacturing (1229)
Marketing (1)
MASH (227)
Medical affairs (1)
Medical device (15259)
Medtech (15428)
Mergers & acquisitions (22969)
Metabolic disorders (1833)
mRNA (272)
Multiple sclerosis (206)
NASH (24)
Neurodegenerative disease (511)
Neuropsychiatric disorders (130)
Neuroscience (3739)
Neurotech (1)
NextGen: Class of 2026 (7665)
Non-profit (5145)
Now hiring (82)
Obesity (873)
Opinion (375)
Ovarian cancer (244)
Pain (285)
Pancreatic cancer (361)
Parkinson's disease (420)
Partnered (37)
Patents (655)
Patient recruitment (771)
Peanut (71)
People (66813)
Pharmaceutical (127)
Pharmacy benefit managers (38)
Phase 1 (24113)
Phase 2 (33995)
Phase 3 (25564)
Pipeline (9913)
Policy (399)
Postmarket research (3264)
Preclinical (10618)
Press Release (72)
Prostate cancer (350)
Psychedelics (71)
Radiopharmaceuticals (373)
Rare diseases (1281)
Real estate (7216)
Recruiting (81)
Regulatory (29731)
Reports (75)
Research institute (2765)
Resumes & cover letters (584)
Rett syndrome (43)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (334)
Series B (242)
Service/supplier (25)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4280)
State (2)
Stomach cancer (21)
Supply chain (147)
Tariffs (104)
The Weekly (140)
Vaccines (1314)
Venture capital (136)
Weight loss (599)
Women's health (141)
Worklife (24)
Date
Today (96)
Last 7 days (532)
Last 30 days (2834)
Last 365 days (32677)
2026 (16608)
2025 (32534)
2024 (37884)
2023 (42563)
2022 (53926)
2021 (58719)
2020 (57660)
2019 (51298)
2018 (39079)
2017 (36828)
2016 (37738)
2015 (43730)
2014 (38412)
2013 (34391)
2012 (36287)
2011 (36403)
2010 (35833)
Location
Africa (1217)
Alabama (102)
Alaska (7)
Arizona (385)
Arkansas (16)
Asia (50857)
Australia (8728)
California (14449)
Canada (4015)
China (1586)
Colorado (623)
Connecticut (641)
Delaware (446)
Europe (115586)
Florida (2160)
Georgia (469)
Hawaii (4)
Idaho (69)
Illinois (1237)
India (104)
Indiana (667)
Iowa (26)
Japan (607)
Kansas (142)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1748)
Massachusetts (10581)
Michigan (414)
Minnesota (805)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (91)
New Jersey (3837)
New Mexico (35)
New York (3799)
North Carolina (1935)
North Dakota (11)
Northern California (7196)
Ohio (451)
Oklahoma (27)
Oregon (53)
Pennsylvania (2835)
Puerto Rico (33)
Rhode Island (55)
South America (1580)
South Carolina (88)
South Dakota (2)
Southern California (5684)
Tennessee (231)
Texas (2341)
United States (51627)
Utah (431)
Vermont (2)
Virginia (373)
Washington D.C. (89)
Washington State (1184)
West Virginia (4)
Wisconsin (158)
Wyoming (2)
854,545 Results for "guangzhou xiangxue pharmaceutical co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Guangzhou Lupeng/Newave Pharmaceutical Inc. Enrolled the First Patient in the Global Phase 3 ROCKET-CLL Trial Evaluating Rocbrutinib (LP-168) vs. Pirtobrutinib in R/R CLL/SLL
Head-to-Head Study Highlights Rocbrutinib as the World’s First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resistance Mutations
May 21, 2026
·
1 min read
Press Releases
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
June 17, 2026
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Press Releases
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
April 21, 2026
·
4 min read
Press Releases
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
January 12, 2026
·
5 min read
Press Releases
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
April 9, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Press Releases
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
January 12, 2026
·
3 min read
Press Releases
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
April 16, 2026
·
8 min read
1 of 85,455
Next
